on 15 Feb 2024
Last Applicant/ Owned by
Zählerweg 10
Zug
CH
6300
Serial Number
97660848 filed on 03rd Nov 2022
Registration Number
N/A
Correspondent Address
Camille M. Miller
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
"EYES"
"EYES" Advertising, promotion of pharmaceutical, medical and cosmetics solutions for the skin injectable pharmaceutical products for use in dermatology; medical preparations consisting of a dermatological preparation, individually or in a set, with pre-filled syringes and vials, for filling lines, wrinkles, scars, lips, for tightening the face and body contouring and for rejuvenating the skin; sRead More
Educational services, namely, providing training in the pharmaceutical, medical and cosmetic fields, arranging and conducting educational conferences, congresses and seminars in the pharmaceutical, medical and cosmetic fields, publication of magazines, books, and guides in the field of medicine and cosmetics
Advertising, promotion of pharmaceutical, medical and cosmetics solutions for the skin
injectable pharmaceutical products for use in dermatology; medical preparations consisting of a dermatological preparation, individually or in a set, with pre-filled syringes and vials, for filling lines, wrinkles, scars, lips, for tightening the face and body contouring and for rejuvenating the skin; synthetic injectable material for use in the treatment of fine lines and wrinkles and for rejuvenating the skin
No 97660848
No Service Mark
No GALD0984US
Yes
No
No
Yes
No
No
No
No
Status Date | Action Taken |
---|---|
16th Feb 2024 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
09th Feb 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
05th Jan 2024 | ASSIGNED TO LIE |
05th Jan 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
05th Jan 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
09th Aug 2023 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
18th Jul 2023 | SUSPENSION LETTER WRITTEN |
18th Jul 2023 | LETTER OF SUSPENSION E-MAILED |
18th Jul 2023 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
31st May 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |